Uric acid in hypertension and cardiovascular disease

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. F, 1999, Pages

  Alderman, M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary disease; Hypertension; Risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; LOSARTAN; URIC ACID;

BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HYPERTENSION; INCIDENCE; REVIEW; RISK FACTOR; SURVIVAL RATE;

ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CORONARY DISEASE; HUMANS; HYPERTENSION; INCIDENCE; LOSARTAN; RECEPTORS, ANGIOTENSIN; RISK FACTORS; SURVIVAL RATE; URIC ACID;

EID: 0033220413     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Rosamond D, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
2. Levy D, Thom TJ. Death rates from coronary disease - progress and a puzzling paradox. N Engl J Med 1998;339:915-6.
3. Collins P, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
4. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998;352:670-1.
5. Langford HG, Blaufox MD, Borhani NO, et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987;147:645-9.
6. Nakashima U, Uematsu T, Kolsuge K, Kanamaru M. Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects. Eur J Clin Pharmacol 1992;42:333-5.
7. Burnier M, Rutschmann B, Nussberger J, et al. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 1993;22:339-47.
8. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998;16:761-9.